MoneyWorks4Me

Jagsonpal Pharmaceuticals informs about investor presentation

22 Feb 2022 Evaluate

With reference to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended (‘Listing Regulations’), Jagsonpal Pharmaceuticals has informed that it enclosed the Investor Presentation.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1752.40
Dr. Reddys Labs. 1233.30
Cipla 1331.00
Lupin 1968.55
Zydus Lifesciences 1124.80
View more..